Structure Therapeutics
The Director of Analytical Development at Structure Therapeutics leads analytical development activities for late-stage drug development, commercialization, and global regulatory filings. The role involves overseeing method development, validation, and regulatory strategy while supporting cross-functional CMC teams and external partners.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
11% above the average for this role
Lead and mentor the Oligonucleotide & Small Molecule CMC Analytical Development team
Denali Therapeutics
Senior Scientist, Analytical Development and Quality Control (Drug Product)
Nurix
Senior Director, Analytical Development, CMC Small Molecule
Centessa Pharmaceuticals
Analytical Development Lead
Relay Therapeutics
Senior Director of Analytical Development
Centessa Pharmaceuticals
Associate Director, Analytical Development
Olema Oncology